Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

F

FATE

Fate Therapeutics Inc

2.01

Nov 03 • 4:53 AM ET -0.00 (-0.18%)

Healthcare Biotechnology USA Micro NASD

Peers: IPSC ALLO NKTX SANA ARTV CABA KYTX CRBU CLLS ACET

| Held by: VTI VXF SCHA IWC VHT PRFZ BUSM AVSC SCHB DFMC

Scroll to Statements

Index	-
Market Cap	240.40M
Enterprise Value	162.30M
Income	-126.00M
Sales	6.49M
Book/sh	1.31
Cash/sh	1.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	161
IPO	Oct 01, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	37.04
P/B	1.53
P/C	1.56
P/FCF	-
EV/EBITDA	-
EV/Sales	25.01
Quick Ratio	4.85
Current Ratio	4.85
Debt/Eq	0.49
LT Debt/Eq	0.46
Option/Short	Yes / Yes

EPS (ttm)	-1.05
EPS next Y	-1.06
EPS next Q	-0.27
EPS this Y	7.39%
EPS next Y	0.55%
EPS next 5Y	1.26%
EPS past 3/5Y	26.67% 11.42%
Sales past 3/5Y	-58.98% -26.71%
EPS Y/Y TTM	27.52%
Sales Y/Y TTM	-23.36%
EPS Q/Q	12.84%
Sales Q/Q	9.18%
Earnings	Aug 13 BMO
EPS/Sales Surpr.	6.47% 55.35%

Insider Own	4.67%
Insider Trans	-2.39%
Inst Own	57.95%
Inst Trans	-1.07%
ROA	-39.89%
ROE	-60.75%
ROIC	-56.20%
Gross Margin	-84.69%
Oper. Margin	-2058.08%
Profit Margin	-1941.09%
SMA20	-2.12%
SMA50	-11.78%
SMA200	2.05%
Trades

Shs Outstand	116.69M
Shs Float	114.23M
Short Float	9.30%
Short Ratio	6.75
Short Interest	10.62M
52W High	3.23 -37.89%
52W Low	0.95 111.19%
Volatility	6.31% 7.14%
ATR (14)	0.13
RSI (14)	41.44
Beta	2.66
Rel Volume	0.00
Avg Volume	1.57M
Volume	4

Perf Week	-3.08%
Perf Month	-17.44%
Perf Quarter	-22.83%
Perf Half Y	-14.99%
Perf YTD	104.18%
Perf Year	59.23%
Perf 3Y	-16.05%
Perf 5Y	-96.68%
Perf 10Y	4.49%
Recom	2.00
Target Price	6.07
Prev Close	2.01
Price	2.01
Change %	-0.18%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)